NASH limits anti-tumour surveillance in immunotherapy-treated HCC
2021-01-01 Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jörn M; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jörg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rössler, Fabian; Siebenhüner, Alexander; Dosso, Sara De; Mallm, Jan-Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G; Billeter, Adrian; Müller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E; Schulz, Axel Ronald; Ringelhan, Marc; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz De Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi-Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N; Decaens, Thomas; Pinato, David J; Rad, Roland; Mertens, Joachim C; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet, Josep M; Heikenwalder, Mathias
Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
2020-01-01 Personeni, N; Pressiani, T; Rimassa, L
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2013-01-01 Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A
Which choice of therapy when many are available? - Current systemic therapies for advanced hepatocellular carcinoma
In corso di stampa Personeni, N; Pressiani, T; Rimassa, L
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
2010-01-01 Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P.
COVID-19 and liver cancer clinical trials: not everything is lost
2020-01-01 D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
2022-01-01 Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini
Prognostic value of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: an exploratory analysis from the second-line ARQ 197-215 study
2017-01-01 Personeni, N; Giordano, L; Abbadessa, G; Porta, C; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, Jl; Van Vlierberghe, H; Trojan, J; De Toni, En; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Lamar, Me; Wang, Y; Shuster, D; Schwartz, B; Santoro, A; Rimassa, L
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study
2018-01-01 Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A
Biomarkers in Hepatocellular Carcinoma-Letter
2012-01-01 Personeni, N; Rimassa, L; Santoro, A
Exploring novel avenues for neoadjuvant treatment of hepatocellular carcinoma
2022-01-01 Personeni, Nicola; Rimassa, Lorenza
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
2008-01-01 W, De Roock; H, Piessevaux; J, De Schutter; M, Janssens; G, De Hertogh; Personeni, N.; B, Biesmans; Laethem Jl, Van; M, Peeters; Y, Humblet; E, Van Cutsem; S., Tejpar
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
2020-01-01 Fessas, Petros; Kaseb, Ahmed; Wang, Yinghong; Saeed, Anwaar; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Rafeh Naqash, Abdul; Muzaffar, Mahvish; Navaid, Musharraf; Khan, Uqba; Lee, Chiehju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Benevento, Francesca; Hildebrand, Hannah; Pressiani, Tiziana; Abugabal, Yehia I; Personeni, Nicola; Huang, Yi-Hsiang; Rimassa, Lorenza; Ang, Celina; Marron, Thomas; Pinato, David J
Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner
2020-01-01 Campani, Claudia; Rimassa, Lorenza; Personeni, Nicola; Marra, Fabio
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
2019-01-01 Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
2024-01-01 Rimini, Margherita; Fornaro, Lorenzo; Rizzato, Mario Domenico; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Vandeputte, Hanne; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Chon, Hong Jae; Braconi, Chiara; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W.; Avallone, Antonio; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L.; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Foti, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Masi, Gianluca; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications
2017-01-01 Personeni, N; Baretti, M; Bozzarelli, S; Spaggiari, P; Rubino, L; Tronconi, Mc; Fumagalli Romario, U; Rosati, R; Giordano, L; Roncalli, M; Santoro, A; Rimassa, L
Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinoma
2021-01-01 Personeni, Nicola; Rimassa, Lorenza
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
2024-01-01 Lo Prinzi, Federica; Salani, Francesca; Rimini, Margherita; Rizzato, Mario Domenico; Antonuzzo, Lorenzo; Camera, Silvia; Satake, Tomoyuki; Vandeputte, Hanne; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Pircher, Chiara; Chon, Hong Jae; Braconi, Chiara; Pastorino, Alessandro; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W; Avallone, Antonio; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Melo Alvim, Cecilia; Roque, Ricardo; Fornaro, Lorenzo; De Rosa, Antonio; Lavacchi, Daniele; Rossari, Federico; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Viola, Massimo Giuseppe; Silvestro, Lucrezia; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Ahcene Djaballah, Selma; Zanuso, Valentina; Masi, Gianluca; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
2022-01-01 Wu, Yue Linda; Fulgenzi, Claudia Angela Maria; D'Alessio, Antonio; Cheon, Jaekyung; Nishida, Naoshi; Saeed, Anwaar; Wietharn, Brooke; Cammarota, Antonella; Pressiani, Tiziana; Personeni, Nicola; Pinter, Matthias; Scheiner, Bernhard; Balcar, Lorenz; Huang, Yi-Hsiang; Phen, Samuel; Naqash, Abdul Rafeh; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Galle, Peter R; Kudo, Masatoshi; Rimassa, Lorenza; Singal, Amit G; Sharma, Rohini; Cortellini, Alessio; Gaillard, Vincent E; Chon, Hong Jae; Pinato, David J; Ang, Celina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC | 1-gen-2021 | Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jörn M; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jörg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rössler, Fabian; Siebenhüner, Alexander; Dosso, Sara De; Mallm, Jan-Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G; Billeter, Adrian; Müller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E; Schulz, Axel Ronald; Ringelhan, Marc; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz De Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi-Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N; Decaens, Thomas; Pinato, David J; Rad, Roland; Mertens, Joachim C; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet, Josep M; Heikenwalder, Mathias | |
| Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma | 1-gen-2020 | Personeni, N; Pressiani, T; Rimassa, L | |
| A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma | 1-gen-2013 | Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A | |
| Which choice of therapy when many are available? - Current systemic therapies for advanced hepatocellular carcinoma | In corso di stampa | Personeni, N; Pressiani, T; Rimassa, L | |
| Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy | 1-gen-2010 | Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P. | |
| COVID-19 and liver cancer clinical trials: not everything is lost | 1-gen-2020 | D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L | |
| Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma | 1-gen-2022 | Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini | |
| Prognostic value of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: an exploratory analysis from the second-line ARQ 197-215 study | 1-gen-2017 | Personeni, N; Giordano, L; Abbadessa, G; Porta, C; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, Jl; Van Vlierberghe, H; Trojan, J; De Toni, En; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Lamar, Me; Wang, Y; Shuster, D; Schwartz, B; Santoro, A; Rimassa, L | |
| Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study | 1-gen-2018 | Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A | |
| Biomarkers in Hepatocellular Carcinoma-Letter | 1-gen-2012 | Personeni, N; Rimassa, L; Santoro, A | |
| Exploring novel avenues for neoadjuvant treatment of hepatocellular carcinoma | 1-gen-2022 | Personeni, Nicola; Rimassa, Lorenza | |
| KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab | 1-gen-2008 | W, De Roock; H, Piessevaux; J, De Schutter; M, Janssens; G, De Hertogh; Personeni, N.; B, Biesmans; Laethem Jl, Van; M, Peeters; Y, Humblet; E, Van Cutsem; S., Tejpar | |
| Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study | 1-gen-2020 | Fessas, Petros; Kaseb, Ahmed; Wang, Yinghong; Saeed, Anwaar; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Rafeh Naqash, Abdul; Muzaffar, Mahvish; Navaid, Musharraf; Khan, Uqba; Lee, Chiehju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Benevento, Francesca; Hildebrand, Hannah; Pressiani, Tiziana; Abugabal, Yehia I; Personeni, Nicola; Huang, Yi-Hsiang; Rimassa, Lorenza; Ang, Celina; Marron, Thomas; Pinato, David J | |
| Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner | 1-gen-2020 | Campani, Claudia; Rimassa, Lorenza; Personeni, Nicola; Marra, Fabio | |
| Targeted agents for second-line treatment of advanced hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L | |
| Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population | 1-gen-2024 | Rimini, Margherita; Fornaro, Lorenzo; Rizzato, Mario Domenico; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Vandeputte, Hanne; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Chon, Hong Jae; Braconi, Chiara; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W.; Avallone, Antonio; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L.; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Foti, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Masi, Gianluca; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea | |
| Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications | 1-gen-2017 | Personeni, N; Baretti, M; Bozzarelli, S; Spaggiari, P; Rubino, L; Tronconi, Mc; Fumagalli Romario, U; Rosati, R; Giordano, L; Roncalli, M; Santoro, A; Rimassa, L | |
| Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinoma | 1-gen-2021 | Personeni, Nicola; Rimassa, Lorenza | |
| Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population | 1-gen-2024 | Lo Prinzi, Federica; Salani, Francesca; Rimini, Margherita; Rizzato, Mario Domenico; Antonuzzo, Lorenzo; Camera, Silvia; Satake, Tomoyuki; Vandeputte, Hanne; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Pircher, Chiara; Chon, Hong Jae; Braconi, Chiara; Pastorino, Alessandro; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W; Avallone, Antonio; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Melo Alvim, Cecilia; Roque, Ricardo; Fornaro, Lorenzo; De Rosa, Antonio; Lavacchi, Daniele; Rossari, Federico; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Viola, Massimo Giuseppe; Silvestro, Lucrezia; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Ahcene Djaballah, Selma; Zanuso, Valentina; Masi, Gianluca; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea | |
| Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab | 1-gen-2022 | Wu, Yue Linda; Fulgenzi, Claudia Angela Maria; D'Alessio, Antonio; Cheon, Jaekyung; Nishida, Naoshi; Saeed, Anwaar; Wietharn, Brooke; Cammarota, Antonella; Pressiani, Tiziana; Personeni, Nicola; Pinter, Matthias; Scheiner, Bernhard; Balcar, Lorenz; Huang, Yi-Hsiang; Phen, Samuel; Naqash, Abdul Rafeh; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Galle, Peter R; Kudo, Masatoshi; Rimassa, Lorenza; Singal, Amit G; Sharma, Rohini; Cortellini, Alessio; Gaillard, Vincent E; Chon, Hong Jae; Pinato, David J; Ang, Celina |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista71908
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa64
- 2020 - 202616999
- 2010 - 201923026
- 2000 - 200918345
- 1990 - 19998891
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI972
- Elsevier Ltd761
- Elsevier B.V.651
- MDPI AG497
- Elsevier391
- John Wiley and Sons Inc327
- Springer321
- Multidisciplinary Digital Publish...309
- Springer Science and Business Med...299
- Elsevier Inc.264
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE384
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS282
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...196
- DOCTOR. OS183
- ACTA BIOMEDICA182
- NUTRIENTS180
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2917
- Female1597
- Male1493
- Middle Aged904
- Adult898
- Aged760
- Animals652
- Italy592
- Medicine (all)464
- COVID-19459
Lingua
- eng43532
- ita9129
- fre232
- spa124
- ger99
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext58598
- reserved8052
- open3768
- partially open822
- restricted667
- embargoed2
- mixed1